Table 3.
Incidence of primary and secondary endpoints
| All patients (n = 83) | SV carriers (n = 20) | NSV carriers (n = 12) | Noncarriers (n = 51) | p | |
|---|---|---|---|---|---|
| Primary endpoint | |||||
| Death and heart transplantation, n (%) | 28 (33.7) | 8 (40.0) | 8 (66.7) | 12 (23.5) | A; c |
| Secondary endpoints | |||||
| All‐cause death, n (%) | 24 (28.9) | 6 (30.0) | 6 (50.0) | 12 (23.5) | NS |
| Heart transplantation, n (%) | 4 (4.8) | 2 (10.0) | 2 (16.7) | 0 (0.0) | A; c |
| Cardiovascular death, n (%) | 24 (28.9) | 6 (30.0) | 6 (50.0) | 12 (23.5) | NS |
| Sudden cardiac death, n (%) | 4 (4.8) | 1 (5.0) | 0 (0.0) | 3 (5.9) | NS |
| Heart failure‐related death, n (%) | 19 (22.9) | 5 (25.0) | 6 (50.0) | 8 (15.7) | A; c |
p values: A, significant difference between three groups; c, significant difference between the NSV Carriers group and Non‐carriers group; NS, not significant.